The first 2 authors contributed equally to this work.
Article first published online: 16 DEC 2011
Copyright © 2011 American Cancer Society
Volume 118, Issue 17, pages 4228–4234, 1 September 2012
How to Cite
Lawrence, Y. R., Mishra, M. V., Werner-Wasik, M., Andrews, D. W., Showalter, T. N., Glass, J., Shen, X., Symon, Z. and Dicker, A. P. (2012), Improving prognosis of glioblastoma in the 21st century: Who has benefited most?. Cancer, 118: 4228–4234. doi: 10.1002/cncr.26685
See related article:
- Issue published online: 20 AUG 2012
- Article first published online: 16 DEC 2011
- Manuscript Accepted: 22 SEP 2011
- Manuscript Revised: 2 SEP 2011
- Manuscript Received: 21 JUN 2011
- 2European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352: 987-996., , , et al;
- 3Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466). Cancer. 2010; 116: 1844-1846..